ALFA Filings
Every announcement, straight from the exchange
Every Granules India results update announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Granules India reported Q2FY27 revenue of INR 15,600 Mn, up 20% YoY, and PAT of INR 1,818 Mn, up 39%. The company also cited a net cash position and a US FDA audit at its Gagillapur site.
Granules India reported Q1 FY27 revenue of ₹1,476.8 Crore, up 22% YoY. PAT grew 60% YoY to reach ₹180 Crore.
Granules India reported Q4FY26 revenue of ₹1470.6 Crore, up 23% YoY, with PAT rising 33% to ₹201.6 Crore. Annual FY26 revenue reached ₹5,365.6 Crore, a 20% growth. Performance was driven by portfolio expansion and the Peptides CDMO platform, alongside significant debt reduction and improved ROCE of 17.6%.